Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy

J Telemed Telecare. 2016 Jul;22(5):277-81. doi: 10.1177/1357633X15598425. Epub 2015 Aug 18.

Abstract

Telemedicine in diabetes includes telemonitoring and transmission of important data (self monitoring of blood glucose data, insulin therapy, pump setting, etc.) from the patient s home to the diabetic unit, with a real-time health feedback. Moreover, an eHealth approach is thought to facilitate diabetes management and to improve compliance to CSII/SAP treatment in adolescents, but to date, limited literature related to this topic is available and long-term studies are still lacking. The main aim of this study was to compare the long-term effect on glycometabolic control of eHealth intervention and traditional care in T1DM SAP-treated adolescents. In our study we demonstrated a favorable impact of monthly teleassistance on treatment compliance. Adolescents receiving frequent feedback provided by the medicalmultidisciplinary team, due to the telemonitoring, resulted more compliant in self-management of diabetes. In particular, the medical team feedback resulted in interventions on behavioral errors and insulin therapy adjustments, leading to an improved glycometabolic control.

Keywords: Telecare; eHealth; teleconsulting; telehealth; telemedicine.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Blood Glucose Self-Monitoring
  • Diabetes Mellitus, Type 1 / therapy*
  • Female
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use*
  • Insulin / administration & dosage
  • Insulin / therapeutic use*
  • Insulin Infusion Systems
  • Male
  • Monitoring, Ambulatory / methods*
  • Patient Care Team / organization & administration
  • Patient Compliance / statistics & numerical data*
  • Patient Education as Topic / organization & administration
  • Self Care
  • Telemedicine / organization & administration*

Substances

  • Hypoglycemic Agents
  • Insulin